Gastro Esophageal Reflux Disease (GERD) Drug Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Gastro Esophageal Reflux Disease (GERD) Drug in global, including the following market information:
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Gastro Esophageal Reflux Disease (GERD) Drug companies in 2021 (%)
The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
H2 Receptor Antagonist Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug include Pfizer, Novartis AG, GlaxoSmithKline, Merck, Medtronic, The Kroger Co., Aros Pharma, AstraZeneca, Plc. and Addex Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastro Esophageal Reflux Disease (GERD) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastro Esophageal Reflux Disease (GERD) Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Segment Percentages, by Type, 2021 (%)
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Segment Percentages, by Application, 2021 (%)
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Gastro Esophageal Reflux Disease (GERD) Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastro Esophageal Reflux Disease (GERD) Drug revenues share in global market, 2021 (%)
Key companies Gastro Esophageal Reflux Disease (GERD) Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Gastro Esophageal Reflux Disease (GERD) Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Gastro Esophageal Reflux Disease (GERD) Drug companies in 2021 (%)
The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
H2 Receptor Antagonist Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug include Pfizer, Novartis AG, GlaxoSmithKline, Merck, Medtronic, The Kroger Co., Aros Pharma, AstraZeneca, Plc. and Addex Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastro Esophageal Reflux Disease (GERD) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastro Esophageal Reflux Disease (GERD) Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Segment Percentages, by Type, 2021 (%)
- H2 Receptor Antagonist
- Proton Pump Inhibitor (PPi)
- Antacids
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Medical Center
- Others
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Gastro Esophageal Reflux Disease (GERD) Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastro Esophageal Reflux Disease (GERD) Drug revenues share in global market, 2021 (%)
Key companies Gastro Esophageal Reflux Disease (GERD) Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Gastro Esophageal Reflux Disease (GERD) Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis AG
- GlaxoSmithKline
- Merck
- Medtronic
- The Kroger Co.
- Aros Pharma
- AstraZeneca, Plc.
- Addex Therapeutics
- Takeda Pharmaceutical Company Limited
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) DRUG OVERALL MARKET SIZE
2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size: 2021 VS 2028
2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Gastro Esophageal Reflux Disease (GERD) Drug Players in Global Market
3.2 Top Global Gastro Esophageal Reflux Disease (GERD) Drug Companies Ranked by Revenue
3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Companies
3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Companies
3.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gastro Esophageal Reflux Disease (GERD) Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastro Esophageal Reflux Disease (GERD) Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastro Esophageal Reflux Disease (GERD) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastro Esophageal Reflux Disease (GERD) Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Markets, 2021 & 2028
4.1.2 H2 Receptor Antagonist
4.1.3 Proton Pump Inhibitor (PPi)
4.1.4 Antacids
4.2 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue & Forecasts
4.2.1 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2022
4.2.2 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2023-2028
4.2.3 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales & Forecasts
4.3.1 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2022
4.3.2 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2023-2028
4.3.3 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
4.4 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Medical Center
5.1.5 Others
5.2 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue & Forecasts
5.2.1 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2022
5.2.2 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2023-2028
5.2.3 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales & Forecasts
5.3.1 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2022
5.3.2 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2023-2028
5.3.3 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
5.4 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2021 & 2028
6.2 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue & Forecasts
6.2.1 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2022
6.2.2 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2023-2028
6.2.3 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales & Forecasts
6.3.1 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2022
6.3.2 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2023-2028
6.3.3 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.4.2 By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.4.3 US Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.4.4 Canada Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.4.5 Mexico Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.5.2 By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.5.3 Germany Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.4 France Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.5 U.K. Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.6 Italy Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.7 Russia Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.8 Nordic Countries Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.9 Benelux Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.6.2 By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.6.3 China Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.4 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.5 South Korea Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.6 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.7 India Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.7.2 By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.7.3 Brazil Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.7.4 Argentina Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.8.3 Turkey Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8.4 Israel Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8.6 UAE Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis AG
7.2.1 Novartis AG Corporate Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.2.5 Novartis AG Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.4.5 Merck Key News
7.5 Medtronic
7.5.1 Medtronic Corporate Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.5.5 Medtronic Key News
7.6 The Kroger Co.
7.6.1 The Kroger Co. Corporate Summary
7.6.2 The Kroger Co. Business Overview
7.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.6.5 The Kroger Co. Key News
7.7 Aros Pharma
7.7.1 Aros Pharma Corporate Summary
7.7.2 Aros Pharma Business Overview
7.7.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.7.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.7.5 Aros Pharma Key News
7.8 AstraZeneca, Plc.
7.8.1 AstraZeneca, Plc. Corporate Summary
7.8.2 AstraZeneca, Plc. Business Overview
7.8.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.8.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.8.5 AstraZeneca, Plc. Key News
7.9 Addex Therapeutics
7.9.1 Addex Therapeutics Corporate Summary
7.9.2 Addex Therapeutics Business Overview
7.9.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.9.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.9.5 Addex Therapeutics Key News
7.10 Takeda Pharmaceutical Company Limited
7.10.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.10.2 Takeda Pharmaceutical Company Limited Business Overview
7.10.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.10.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.10.5 Takeda Pharmaceutical Company Limited Key News
8 GLOBAL GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity, 2017-2028
8.2 Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) DRUG SUPPLY CHAIN ANALYSIS
10.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Value Chain
10.2 Gastro Esophageal Reflux Disease (GERD) Drug Upstream Market
10.3 Gastro Esophageal Reflux Disease (GERD) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) DRUG OVERALL MARKET SIZE
2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size: 2021 VS 2028
2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Gastro Esophageal Reflux Disease (GERD) Drug Players in Global Market
3.2 Top Global Gastro Esophageal Reflux Disease (GERD) Drug Companies Ranked by Revenue
3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Companies
3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Companies
3.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gastro Esophageal Reflux Disease (GERD) Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastro Esophageal Reflux Disease (GERD) Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastro Esophageal Reflux Disease (GERD) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastro Esophageal Reflux Disease (GERD) Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Markets, 2021 & 2028
4.1.2 H2 Receptor Antagonist
4.1.3 Proton Pump Inhibitor (PPi)
4.1.4 Antacids
4.2 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue & Forecasts
4.2.1 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2022
4.2.2 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2023-2028
4.2.3 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales & Forecasts
4.3.1 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2022
4.3.2 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2023-2028
4.3.3 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
4.4 By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Medical Center
5.1.5 Others
5.2 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue & Forecasts
5.2.1 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2022
5.2.2 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2023-2028
5.2.3 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales & Forecasts
5.3.1 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2022
5.3.2 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2023-2028
5.3.3 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
5.4 By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2021 & 2028
6.2 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue & Forecasts
6.2.1 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2022
6.2.2 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2023-2028
6.2.3 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales & Forecasts
6.3.1 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2022
6.3.2 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2023-2028
6.3.3 By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.4.2 By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.4.3 US Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.4.4 Canada Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.4.5 Mexico Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.5.2 By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.5.3 Germany Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.4 France Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.5 U.K. Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.6 Italy Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.7 Russia Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.8 Nordic Countries Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.5.9 Benelux Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.6.2 By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.6.3 China Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.4 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.5 South Korea Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.6 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.6.7 India Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.7.2 By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.7.3 Brazil Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.7.4 Argentina Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales, 2017-2028
6.8.3 Turkey Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8.4 Israel Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
6.8.6 UAE Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis AG
7.2.1 Novartis AG Corporate Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.2.5 Novartis AG Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.4.5 Merck Key News
7.5 Medtronic
7.5.1 Medtronic Corporate Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.5.5 Medtronic Key News
7.6 The Kroger Co.
7.6.1 The Kroger Co. Corporate Summary
7.6.2 The Kroger Co. Business Overview
7.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.6.5 The Kroger Co. Key News
7.7 Aros Pharma
7.7.1 Aros Pharma Corporate Summary
7.7.2 Aros Pharma Business Overview
7.7.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.7.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.7.5 Aros Pharma Key News
7.8 AstraZeneca, Plc.
7.8.1 AstraZeneca, Plc. Corporate Summary
7.8.2 AstraZeneca, Plc. Business Overview
7.8.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.8.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.8.5 AstraZeneca, Plc. Key News
7.9 Addex Therapeutics
7.9.1 Addex Therapeutics Corporate Summary
7.9.2 Addex Therapeutics Business Overview
7.9.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.9.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.9.5 Addex Therapeutics Key News
7.10 Takeda Pharmaceutical Company Limited
7.10.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.10.2 Takeda Pharmaceutical Company Limited Business Overview
7.10.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Major Product Offerings
7.10.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales and Revenue in Global (2017-2022)
7.10.5 Takeda Pharmaceutical Company Limited Key News
8 GLOBAL GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity, 2017-2028
8.2 Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) DRUG SUPPLY CHAIN ANALYSIS
10.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Value Chain
10.2 Gastro Esophageal Reflux Disease (GERD) Drug Upstream Market
10.3 Gastro Esophageal Reflux Disease (GERD) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Gastro Esophageal Reflux Disease (GERD) Drug in Global Market
Table 2. Top Gastro Esophageal Reflux Disease (GERD) Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Companies, 2017-2022
Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
Table 9. List of Global Tier 1 Gastro Esophageal Reflux Disease (GERD) Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastro Esophageal Reflux Disease (GERD) Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 48. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Novartis AG Corporate Summary
Table 50. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 51. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. GlaxoSmithKline Corporate Summary
Table 53. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 54. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Merck Corporate Summary
Table 56. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 57. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Medtronic Corporate Summary
Table 59. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 60. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. The Kroger Co. Corporate Summary
Table 62. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 63. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Aros Pharma Corporate Summary
Table 65. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 66. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. AstraZeneca, Plc. Corporate Summary
Table 68. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 69. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Addex Therapeutics Corporate Summary
Table 71. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 72. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Takeda Pharmaceutical Company Limited Corporate Summary
Table 74. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 75. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 77. Global Gastro Esophageal Reflux Disease (GERD) Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Gastro Esophageal Reflux Disease (GERD) Drug Production by Region, 2017-2022 (K Pcs)
Table 79. Global Gastro Esophageal Reflux Disease (GERD) Drug Production by Region, 2023-2028 (K Pcs)
Table 80. Gastro Esophageal Reflux Disease (GERD) Drug Market Opportunities & Trends in Global Market
Table 81. Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers in Global Market
Table 82. Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints in Global Market
Table 83. Gastro Esophageal Reflux Disease (GERD) Drug Raw Materials
Table 84. Gastro Esophageal Reflux Disease (GERD) Drug Raw Materials Suppliers in Global Market
Table 85. Typical Gastro Esophageal Reflux Disease (GERD) Drug Downstream
Table 86. Gastro Esophageal Reflux Disease (GERD) Drug Downstream Clients in Global Market
Table 87. Gastro Esophageal Reflux Disease (GERD) Drug Distributors and Sales Agents in Global Market
Table 1. Key Players of Gastro Esophageal Reflux Disease (GERD) Drug in Global Market
Table 2. Top Gastro Esophageal Reflux Disease (GERD) Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Companies, 2017-2022
Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
Table 9. List of Global Tier 1 Gastro Esophageal Reflux Disease (GERD) Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastro Esophageal Reflux Disease (GERD) Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales, (K Pcs), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 48. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Novartis AG Corporate Summary
Table 50. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 51. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. GlaxoSmithKline Corporate Summary
Table 53. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 54. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Merck Corporate Summary
Table 56. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 57. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Medtronic Corporate Summary
Table 59. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 60. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. The Kroger Co. Corporate Summary
Table 62. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 63. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Aros Pharma Corporate Summary
Table 65. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 66. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. AstraZeneca, Plc. Corporate Summary
Table 68. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 69. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Addex Therapeutics Corporate Summary
Table 71. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 72. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Takeda Pharmaceutical Company Limited Corporate Summary
Table 74. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Offerings
Table 75. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 77. Global Gastro Esophageal Reflux Disease (GERD) Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Gastro Esophageal Reflux Disease (GERD) Drug Production by Region, 2017-2022 (K Pcs)
Table 79. Global Gastro Esophageal Reflux Disease (GERD) Drug Production by Region, 2023-2028 (K Pcs)
Table 80. Gastro Esophageal Reflux Disease (GERD) Drug Market Opportunities & Trends in Global Market
Table 81. Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers in Global Market
Table 82. Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints in Global Market
Table 83. Gastro Esophageal Reflux Disease (GERD) Drug Raw Materials
Table 84. Gastro Esophageal Reflux Disease (GERD) Drug Raw Materials Suppliers in Global Market
Table 85. Typical Gastro Esophageal Reflux Disease (GERD) Drug Downstream
Table 86. Gastro Esophageal Reflux Disease (GERD) Drug Downstream Clients in Global Market
Table 87. Gastro Esophageal Reflux Disease (GERD) Drug Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type
Figure 2. Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application
Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Gastro Esophageal Reflux Disease (GERD) Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Gastro Esophageal Reflux Disease (GERD) Drug Revenue in 2021
Figure 9. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 19. US Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 24. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 33. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 40. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 44. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Gastro Esophageal Reflux Disease (GERD) Drug by Region, 2020 VS 2027
Figure 50. Gastro Esophageal Reflux Disease (GERD) Drug Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type
Figure 2. Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application
Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Gastro Esophageal Reflux Disease (GERD) Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Gastro Esophageal Reflux Disease (GERD) Drug Revenue in 2021
Figure 9. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 19. US Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 24. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 33. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 40. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share, 2017-2028
Figure 44. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gastro Esophageal Reflux Disease (GERD) Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Gastro Esophageal Reflux Disease (GERD) Drug by Region, 2020 VS 2027
Figure 50. Gastro Esophageal Reflux Disease (GERD) Drug Industry Value Chain
Figure 51. Marketing Channels
